Radiance II

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.
Contact phone
Sparrow Clinical Research Institute 517.364.5760
Principal investigator
Joel Cohn, M.D., FACC
Trial Category
Heart & Vascular
Trial SubCategory
Hypertension